– UK, London – Schroder UK Public-Private Trust plc (LON: SUPP) today announced the appointment of Tim Edwards to its Board as an independent non-executive director, effective 26 February 2021.
Mr. Edwards should succeed Susan Searle as Board Chair following her retirement once the AGM has concluded.
“The appointment of Tim is in line with the Board’s agreed succession plans, as outlined in the Annual Report for the year ended 31 December 2019, and follows an extensive independent search over the last twelve months to find a candidate with the appropriate balance of skills and experience to complement those of the current Directors. My colleagues and I are delighted to welcome him to the Board and are very much looking forward to working with him.” said Board Chair, Susan Searle.
Mr. Edwards has also been appointed a member of the Audit, Risk and Valuation, Management Engagement, and Nomination Committees.
About Tim Edwards
Tim is a qualified chartered accountant with a widespread background in corporate finance and investment. He is currently the chairman of Storm Therapeutics Ltd, Karus Therapeutics Ltd and Modulus Oncology Ltd, a director of AstronauTx Ltd, and an independent non-executive director of Record plc. Previously, Tim was a member of the governing board of InnovateUK, the UK’s innovation agency, a director of the UK Cell and Gene Therapy Catapult, and chairman of the UK BioIndustry Association.
- Disclaimer - News, data, and statements included in this release are intended exclusively for general information purposes. Talent4Boards does not guarantee that news is accurate or about the correct person and accepts neither liability for the consequences of the reader’s reliance, nor responsibility for the accuracy of the information. Nothing in this release should be considered for decisions about referred securities. Products and brand names may be trademarks or registered trademarks of their respective owners.